Preclinical Advances of Therapies for Laminopathies - Sorbonne Université
Article Dans Une Revue Journal of Clinical Medicine Année : 2021

Preclinical Advances of Therapies for Laminopathies

Résumé

Laminopathies are a group of rare disorders due to mutation in LMNA gene. Depending on the mutation, they may affect striated muscles, adipose tissues, nerves or are multisystemic with various accelerated ageing syndromes. Although the diverse pathomechanisms responsible for laminopathies are not fully understood, several therapeutic approaches have been evaluated in patient cells or animal models, ranging from gene therapies to cell and drug therapies. This review is focused on these therapies with a strong focus on striated muscle laminopathies and premature ageing syndromes.
Fichier principal
Vignette du fichier
jcm-10-04834-v3.pdf (1.51 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03430955 , version 1 (16-11-2021)

Identifiants

Citer

Louise Benarroch, Enzo Cohen, Antonio Atalaia, Rabah Ben Yaou, Gisèle Bonne, et al.. Preclinical Advances of Therapies for Laminopathies. Journal of Clinical Medicine, 2021, 10 (21), pp.4834. ⟨10.3390/jcm10214834⟩. ⟨hal-03430955⟩
60 Consultations
67 Téléchargements

Altmetric

Partager

More